Literature DB >> 81971

Beta 2 microglobulin, a tumour marker of lymphoproliferative disorder.

J P Cassuto, B P Krebs, G Viot, P Dujardin, R Masseyeff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 81971     DOI： 10.1016/s0140-6736(78)91677-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era.

Authors:  Seyoung Seo; Jung Yong Hong; Shinkyo Yoon; Changhoon Yoo; Ji Hyun Park; Jung Bok Lee; Chan-Sik Park; Jooryung Huh; Yoonse Lee; Kyung Won Kim; Jin-Sook Ryu; Seok Jin Kim; Won Seog Kim; Dok Hyun Yoon; Cheolwon Suh
Journal:  Oncotarget       Date:  2016-11-22

Review 2.  Gene Expression Profiling in Multiple Myeloma: Redefining the Paradigm of Risk-Adapted Treatment.

Authors:  Claudio Cerchione; Saad Z Usmani; A Keith Stewart; Martin Kaiser; Leo Rasche; Martin Kortüm; María-Victoria Mateos; Andrew Spencer; Pieter Sonneveld; Kenneth C Anderson
Journal:  Front Oncol       Date:  2022-02-08       Impact factor: 6.244

Review 3.  Circulating plasma factors involved in rejuvenation.

Authors:  Jae Sook Kang; Yong Ryoul Yang
Journal:  Aging (Albany NY)       Date:  2020-11-16       Impact factor: 5.682
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.